Millipore Sigma Vibrant Logo

505772 Pirenzepine Dihydrochloride - CAS 28797-61-7 - Calbiochem

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
28797-61-7C₁₉H₂₁N₅O₂•2HCl

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
5057720001
Récupération des données relatives à la disponibilité...
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Flacon en verre 100 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      Demander le prix
      Description
      OverviewAn antagonist selective for mAChR subtype M1. Used for studying the functional roles of M1 receptors in both central and peripheral nervous systems.
      Catalogue Number505772
      Brand Family Calbiochem®
      SynonymsMuscarinic Acetylcholine Receptor (mAChR) M1 Antagonist, Pirenzepine dihydrochloride
      References
      ReferencesShirey, K., et al., 2009. J. Neurosci. 29, 14271.
      Pelat, M., et al., 1999. Eur.J. Pharmacol. 379, 117.
      Burford NT, et al. 1996. Biochem. J. 315, 883.
      Product Information
      CAS number28797-61-7
      FormWhite solid
      Hill FormulaC₁₉H₂₁N₅O₂•2HCl
      Chemical formulaC₁₉H₂₁N₅O₂•2HCl
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetM1
      Purity≥99% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      5057720001 04055977263008

      Documentation

      Pirenzepine Dihydrochloride - CAS 28797-61-7 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Références bibliographiques

      Aperçu de la référence bibliographique
      Shirey, K., et al., 2009. J. Neurosci. 29, 14271.
      Pelat, M., et al., 1999. Eur.J. Pharmacol. 379, 117.
      Burford NT, et al. 1996. Biochem. J. 315, 883.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-September-2013 JSW
      SynonymsMuscarinic Acetylcholine Receptor (mAChR) M1 Antagonist, Pirenzepine dihydrochloride
      DescriptionAn antagonist selective for mAChR subtype M1. Used for studying the functional roles of M1 receptors in both central and peripheral nervous systems.
      FormWhite solid
      CAS number28797-61-7
      Chemical formulaC₁₉H₂₁N₅O₂•2HCl
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityH₂O (100 mM)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesShirey, K., et al., 2009. J. Neurosci. 29, 14271.
      Pelat, M., et al., 1999. Eur.J. Pharmacol. 379, 117.
      Burford NT, et al. 1996. Biochem. J. 315, 883.